Search research articles
Contact Us
Filters
Showing results (41-50 of 250) with videos related to
Page
of 25
Sort By:
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
December 23, 1998
The relationship between capillary and venous concentrations of the antimalarial drug lumefantrine (benflumetol)
M van Vugt, F Ezzet, L Phaipun, et al.
Journal of Environmental Management
|
April 25, 2006
On the relationship between set-out rates and participation ratios as a tool for enhancement of kerbside household waste recycling
P J Shaw, J K Lyas, S J Maynard, et al.
Advances in Protein Chemistry and Structural Biology
|
February 26, 2019
Replication stress: Driver and therapeutic target in genomically instable cancers
Pepijn M Schoonen, Sergi Guerrero Llobet, Marcel A T M van Vugt
Radiology
|
August 1, 1996
First-trimester nuchal translucency: a risk analysis on fetal chromosome abnormality
J M van Vugt, R M van Zalen-Sprock, P J Kostense
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
July 23, 1998
Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks' gestation
J M Van Vugt, B W Tinnemans, R M Van Zalen-Sprock
Nederlands Tijdschrift Voor Geneeskunde
|
August 24, 2005
[Ultrasonography in rheumatological practice]
J W G Jacobs, R M van Vugt, W A A Swen
Annals of the Rheumatic Diseases
|
December 16, 1998
Deforming arthropathy or lupus and rhupus hands in systemic lupus erythematosus
R M van Vugt, R H Derksen, L Kater, et al.
Antimicrobial Agents and Chemotherapy
|
February 19, 2000
Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria
F Ezzet, M van Vugt, F Nosten, et al.
Lancet (London, England)
|
June 13, 1992
Non-echogenic nuchal oedema as a marker in trisomy 21 screening
M M van Zalen-Sprock, J M van Vugt, H P van Geijn
Teratology
|
January 23, 1999
Topical timolol therapy in pregnancy: is it safe for the fetus?
A M Wagenvoort, J M van Vugt, M Sobotka, et al.
Page
of 25
Search research articles
Search
Showing results (41-50 of 250) with videos related to
Sort By:
Page
of 25
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
December 23, 1998
The relationship between capillary and venous concentrations of the antimalarial drug lumefantrine (benflumetol)
M van Vugt, F Ezzet, L Phaipun, et al.
Journal of Environmental Management
|
April 25, 2006
On the relationship between set-out rates and participation ratios as a tool for enhancement of kerbside household waste recycling
P J Shaw, J K Lyas, S J Maynard, et al.
Advances in Protein Chemistry and Structural Biology
|
February 26, 2019
Replication stress: Driver and therapeutic target in genomically instable cancers
Pepijn M Schoonen, Sergi Guerrero Llobet, Marcel A T M van Vugt
Radiology
|
August 1, 1996
First-trimester nuchal translucency: a risk analysis on fetal chromosome abnormality
J M van Vugt, R M van Zalen-Sprock, P J Kostense
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
July 23, 1998
Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks' gestation
J M Van Vugt, B W Tinnemans, R M Van Zalen-Sprock
Nederlands Tijdschrift Voor Geneeskunde
|
August 24, 2005
[Ultrasonography in rheumatological practice]
J W G Jacobs, R M van Vugt, W A A Swen
Annals of the Rheumatic Diseases
|
December 16, 1998
Deforming arthropathy or lupus and rhupus hands in systemic lupus erythematosus
R M van Vugt, R H Derksen, L Kater, et al.
Antimicrobial Agents and Chemotherapy
|
February 19, 2000
Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria
F Ezzet, M van Vugt, F Nosten, et al.
Lancet (London, England)
|
June 13, 1992
Non-echogenic nuchal oedema as a marker in trisomy 21 screening
M M van Zalen-Sprock, J M van Vugt, H P van Geijn
Teratology
|
January 23, 1999
Topical timolol therapy in pregnancy: is it safe for the fetus?
A M Wagenvoort, J M van Vugt, M Sobotka, et al.
Page
of 25